SymBio Pharmaceuticals Limited (4582.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.52B |
| Enterprise Value | 3.62B |
| P/E Ratio | -0.64 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 2.93 |
| Price/Book Ratio | 19.64 |
| Enterprise/Revenue | 2.25 |
| Enterprise/EBITDA | -0.51 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -4.59 |
| Operating Margin | -4.39 |
AD
Management Effectiveness
| Return On Assets | -1.99 |
| Return On Equity | -4.24 |
Income Statement
| Revenue | 1.31B |
| Revenue/Share | 19.09 |
| Gross Profit | 947.34M |
| EBITDA | -4.6B |
| Net Income | -4.78B |
| Diluted EPS | -95.12 |
Balance Sheet
| Total Cash | 1.9B |
| Total Cash/Share | 28.36 |
| Total Debt | 1.03B |
| Total Debt/Equity | 4.43 |
| Current Ratio | 1.11 |
| Book Value Per Share | 3.46 |
Price History
| 52-Week Change | -59.76 |
| 52-Week High | 229 |
| 52-Week Low | 66 |
| Moving Average 50 Days | 83.14 |
| Moving Average 200 Days | 105.51 |
Statistics
| Average Volume | 936,996 |
| Shares Outstanding | 55.12M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | June 26, 2019 |
AD
